Cardinal Health (NYSE:CAH) has initiated a U.S. recall of its Monoject Flush prefilled saline syringes due to an issue with the reintroduction of air.

Dublin, Ohio-based Cardinal Health on Aug. 4 recalled approximately 267 million Monoject Flush devices because they have been found to reintroduce air into the syringe after the air has been expelled, which can potentially result in the injection of air into blood vessels, creating the potential for air embolism leading to serious adverse health outcomes or death.

Get the full story at our sister site, Drug Delivery Business News.